Physician profile
Ashwin V George
NPI 1518169713
$4,224.00
in general payments reported to CMS, 2019-2025
9 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.70 · 2020: $160 · 2021: $548 · 2022: $97.63 · 2023: $1,434 · 2024: $1,505 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,732 · Food and Beverage: $1,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,731.77 |
| Food and Beverage | $1,659.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $3,083.64 | 2023-2025 | Neurostar Tms Therapy System |
| Abbott Laboratories | $535.10 | 2021 | |
| Si-Bone, INC. | $364.84 | 2020-2025 | |
| Electronic Waveform Lab, INC. | $107.03 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $54.18 | 2025 | |
| Nevro Corp. | $38.89 | 2024 | Senza |
| Mdd US Operations, LLC | $15.11 | 2019 | |
| Amgen INC. | $12.62 | 2021 | |
| Supernus Pharmaceuticals, INC. | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashwin George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.